NCT00655148View on ClinicalTrials.gov

Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

817

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Active Immunization
Interventions
BIOLOGICAL

DTaP-IPV vero vaccine

DTaP-IPV vero 0.5 mL solution for intramuscular injection at 2, 3½, 5 and 16 months of age

BIOLOGICAL

DTaP-IPV mkc vaccine

DTaP-IPV mkc 0.5 ml solution for intramuscular injection at 2, 3½, 5 and 16 months of age

Trial Locations (5)

Unknown

Centre Bydgoszcz, Bydgoszcz

Centre Krakow, Krakow

Centre Lodz, Lodz

Centre Poznan, Poznan

Centre Wroclaw, Wroclaw

All Listed Sponsors
lead

Statens Serum Institut

OTHER

NCT00655148 - Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine | Biotech Hunter | Biotech Hunter